MGAT5 and neoplasm: These results lend further support to the notion that Mgat5 loss does not lead to the creation of a strong tumor antigen that evokes a T cell response; rather, an enhancement of the immunogenicity of existing tumor antigens appears to allow for a polyclonal T cell response and robust immune memory.